Peter Bohm
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Patient awareness and perception of cardiovascular risk in rheumatic and musculoskeletal diseases: results from an international survey.
Journal: EULAR rheumatology open
Published: August 01, 2026
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.
Journal: Annals of the rheumatic diseases
Published: February 19, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.
Journal: Seminars in arthritis and rheumatism
Published: October 15, 2025
Compositional patterns of device-measured movement behaviour in juvenile idiopathic arthritis: results from the multicentre ActiMON study.
Journal: Arthritis research & therapy
Published: June 17, 2025
Assessment of the Quality and Readability of Information Provided by ChatGPT in Relation to the Use of Platelet-Rich Plasma Therapy for Osteoarthritis.
Journal: Journal of personalized medicine
Published: April 14, 2024
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update.
Journal: Annals of the rheumatic diseases
Published: January 22, 2024
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
Journal: Seminars in arthritis and rheumatism
Published: September 07, 2023
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Journal: Annals of the rheumatic diseases
Published: May 30, 2023
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Journal: Annals of the rheumatic diseases
Published: September 08, 2022
EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders.
Journal: Annals of the rheumatic diseases
Published: July 21, 2022
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Journal: Annals of the rheumatic diseases
Published: January 24, 2022
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.
Journal: Annals of the rheumatic diseases
Published: February 27, 2021
Last Updated: 09/26/2026